EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma

Clin Lymphoma Myeloma. 2006 Sep;7(2):152-4. doi: 10.3816/CLM.2006.n.055.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Female
  • Humans
  • Isoquinolines / administration & dosage*
  • Isoquinolines / adverse effects
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Male
  • Middle Aged
  • Relapsing Fever

Substances

  • Antineoplastic Agents
  • Isoquinolines
  • pixantrone